SkyePharma to Present at The Banc of America Securities Specialty Pharamceuticals Conference

SkyePharma to Present at The Banc of America Securities Specialty
Pharamceuticals Conference 


LONDON, July 22  /PRNewswire-FirstCall/ -- SkyePharma PLC (LSE:SKPLSE:
Nasdaq:LSE:SKYE) announces today that the Company's Chief Executive Officer,
Michael Ashton, will make a presentation during a panel discussion on the Drug
Delivery Industry at the Banc of America Securities Specialty Pharmaceuticals
Conference on Thursday, July 29th, 2004 at 2.15 p.m. (EST) in New York.
Investors may access a live webcast of the presentation at
http://www.skyepharma.com/ under the Investor Relations tab. For the slides of
this presentation, please visit SkyePharma's website http://www.skyepharma.com/
under Investor Relations / Presentations.

About SkyePharma

SkyePharma develops pharmaceutical products benefiting from world-leading drug
delivery technologies that provide easier-to-use and more effective drug
formulations. There are now ten approved products incorporating SkyePharma's
technologies in the areas of oral, injectable, inhaled and topical delivery,
supported by advanced solubilisation capabilities. For more information, visit
http://www.skyepharma.com/.

   For further information please contact:
   SkyePharma PLC                                     [phone]
   Michael Ashton, Chief Executive Officer
   Peter Laing, Director of Corporate Communications  [phone]
   Sandra Haughton, US Investor Relations             [phone]

   Buchanan Communications                            [phone]
   Tim Anderson / Mark Court


DATASOURCE: SkyePharma PLC



CONTACT:  Michael Ashton, Chief Executive Officer, [phone], or

Peter Laing, Director of Corporate Communications, [phone], or Sandra

Haughton, US Investor Relations, [phone], all of SkyePharma PLC; Tim

Anderson or Mark Court, both of Buchanan Communications,[phone], for

SkyePharma PLC



Web site:  http://www.skyepharma.com/ 

Copyright